Miércoles, 29 de marzo de 16:30 a 18:00 horas

​GENE SILENCING THERAPY FOR HUMAN NEURODEGENERATIVE DISEASE
Prof. Don Cleveland, USA
Head, Laboratory for Cell Biology, Ludwig Institute for Cancer Research
Distinguished Professor and Chair, Dept. of Cellular and Molecular Medicine, Univ. of California
San Diego​, CA
TRANSMISSION OF Α-SYNUCLEIN STRAINS IN SYNUCLEINOPATHIES​
Prof. Virginia Lee, USA​
Perelman School of Medicine at the University of Pennsylvania
The John H. Ware 3rd Professor in Alzheimer’s Research
Director, Center for Neurodegenerative Disease Research and
Marian S. Ware Alzheimer Program
​Philadelphia, PA​

Jueves, 30 de marzo de 08:30 a 09:00 horas

APOE, SYNAPSES, AND ALZHEIMER’S DISEASE​
Prof. Tom Sudhof, USA – 2013 Nobel Prize in Physiology or Medicine
Avram Goldstein Professor, Dept. of Molecular & Cellular Physiology, Stanford University School of Medicine
Stanford CA

Viernes, 31 de marzo de 08:30 a 09:00 horas

​CURRENT DEVELOPMENTS IN THE TREATMENT OF PARKINSON’S DISEASE – FROM DISEASE MODIFICATION TO PREVENTION?
Prof. Werner Poewe, Austria
Director Department of Neurology, Innsbruck Medical University
Innsbruck ​

Sábado, 1 de abril 1 de 08:30 a 09:00 horas

STAGING PATHOLOGY WITH PET​
Prof. Keith Johnson, USA
Massachusetts General Hospital
Boston, MA​​

Domingo, 2 de abril de 08:30​ a 09:00 horas

BLOOD BRAIN BARRIER DYSFUNCTION, NEURODEGENERATION AND ALZHEIMER’S DISEASE 
Prof. Berislav V. Zlokovic, USA​
Keck School of Medicine, Zilkha Neurogenetic Institute, University of Southern California
Los Angeles, CA​
La pasada edición de la Conferencia AD/PD, celebrada en Niza en 2015, reunió a 3.152 participantes procedentes de 81 países. A la edición de este año en Viena está prevista la asistencia de más de 3.500 especialistas.
Para más información sobre la XIII Conference on Alzheimer’s and Parkinson’s Diseases – AD/PD 2017:
Kenes International Organizers of Congresses  http://adpd2017.kenes.com